» Articles » PMID: 19388968

Carotid Intima-media Thickness and Apolipoprotein B/apolipoprotein A-I Ratio in Middle-aged Patients with Type 2 Diabetes

Overview
Journal Diabet Med
Specialty Endocrinology
Date 2009 Apr 25
PMID 19388968
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To explore the association between carotid intima-media thickness (IMT) and the apolipoprotein B (apoB)/apolipoprotein A-I (apoA-I) ratio compared with conventional lipids in middle-aged patients with Type 2 diabetes.

Methods: We analysed data from 247 patients with Type 2 diabetes, aged 55-66 years, in the Cardiovascular Risk factors in Patients with Diabetes-a Prospective study in Primary care (CARDIPP-1) study. Primary care nurses measured blood pressure and anthropometric characteristics. Blood samples were taken for laboratory analyses. The carotid IMT was determined by ultrasonography at the University Hospital in Linköping and at the County Hospital Ryhov, Jönköping, Sweden.

Results: The ApoB/apoA-I ratio (r = 0.207, P = 0.001), apoB (r = 0.166, P = 0.009) and non-high-density lipoprotein cholesterol (non-HDL-c) (r = 0.129, P = 0.046) correlated with IMT. Conventional lipids, high-sensitivity C-reactive protein (hsCRP), glycated haemoglobin (HbA(1c)) and systolic blood pressure were not significantly correlated to IMT. A stepwise logistic regression analysis was conducted with IMT as the dependent variable and the apoB/apoA-I ratio, HbA(1c), hsCRP, low-density lipoprotein cholesterol (LDL-c), total cholesterol, non-HDL-c and treatment with statins as independent variables. Following adjustment for age and gender, only the apoB/apoA-I ratio remained significantly associated with IMT (odds ratio 4.3, 95% confidence intervals 1.7-10.8, P = 0.002).

Conclusions: We conclude that there was a significant association between the apoB/apoA-I ratio and IMT in middle-aged patients with Type 2 diabetes. The association was independent of conventional lipids, hsCRP, glycaemic control and use of statins.

Citing Articles

Plasma Protein Profile of Carotid Artery Atherosclerosis and Atherosclerotic Outcomes: Meta-Analyses and Mendelian Randomization Analyses.

Lind L, Gigante B, Borne Y, Feldreich T, Leppert J, Hedberg P Arterioscler Thromb Vasc Biol. 2021; 41(5):1777-1788.

PMID: 33657885 PMC: 8062283. DOI: 10.1161/ATVBAHA.120.315597.


Using proximity extension proteomics assay to discover novel biomarkers associated with circulating leptin levels in patients with type 2 diabetes.

Vavruch C, Nowak C, Feldreich T, Ostgren C, Sundstrom J, Soderberg S Sci Rep. 2020; 10(1):13097.

PMID: 32753620 PMC: 7403414. DOI: 10.1038/s41598-020-69473-2.


Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes.

Nowak C, Carlsson A, Ostgren C, Nystrom F, Alam M, Feldreich T Diabetologia. 2018; 61(8):1748-1757.

PMID: 29796748 PMC: 6061158. DOI: 10.1007/s00125-018-4641-z.


Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients.

Zhan X, Chen Y, Yan C, Liu S, Deng L, Yang Y Lipids Health Dis. 2018; 17(1):117.

PMID: 29776362 PMC: 5960196. DOI: 10.1186/s12944-018-0771-z.


Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.

Basu A, Jenkins A, Stoner J, Zhang Y, Klein R, Lopes-Virella M J Lipid Res. 2018; 59(5):872-883.

PMID: 29576550 PMC: 5928427. DOI: 10.1194/jlr.P080143.